Thank you for exploring the University of Colorado Hematology Oncology Fellowship Program, where our mission is to develop future world-leaders in academic cancer medicine by providing comprehensive education and training in clinical practice, laboratory research, and clinical, translational and basic science.
We aim to provide an excellent foundation in the clinical practice of medical oncology and hematology based upon a comprehensive understanding of hematological and oncologic principles and treatment techniques. Using their combined professional, technical, cognitive, and attitudinal skills we teach our fellows how to provide the highest quality of care for their patients.
Our fellowship fosters a multidisciplinary approach to cancer and blood-disease care with experienced specialists. Our faculty comes from diverse backgrounds with a wide range of interests including hematology, medical oncology, surgical oncology, pathology, radiation oncology, and radiology. While their interests may differ they all share a common passion for educating young hematologists and oncologists.
Throughout training, we introduce our fellows to collaborative clinical and research opportunities through interactions with our closely associated affiliates which include, University of Colorado Hospital, University of Colorado Cancer Center, Rocky Mountain Regional Veterans Affairs Medical Center, and Denver Health Medical Center.
Our fellows are inquisitive scientists, compassionate skilled physicians, and outstanding teachers. Our program offers the environment and educational resources to help each trainee reach their goals and thrive in their career path. As you explore our program, virtually tour our sites, and discover Denver, we hope you will become excited and inspired by the innovation and cutting edge research of our faculty and fellows.
Daniel Bowles, MD
Associate Professor of Medicine
Fellowship Program Director
The first year of fellowship is focused on intense clinical training in both hematology and oncology and is a largely inpatient-based experience on hematology and oncology consult services. Trainees divide their time in 3 month blocks at University of Colorado Hospital, Denver Health, and the VA. The two blocks at UCH are divided into solid tumor oncology and benign and malignant hematology.
Fellows learn the science of the diagnosis and treatment of hematologic and oncologic diseases, the art of consultation, and the skills necessary to care for patients with these problems. This inpatient training is complemented by weekly outpatient continuity clinic and sub-specialty clinic experience.
Elective time during the first year allows for additional exposure to disease-specific sub-specialty clinics and the opportunity to work with leading faculty in areas of solid tumor oncology, hematologic malignancies, benign hematology, and radiation oncology.
|School||University of Colorado|
Hematology and Medical Oncology
|Required Documents for All Applicants|
|USMLE or COMLEX Transcript|
|Three Letters of Recommendation (Not Including Program Director)|
|Program Director Letter of Recommendation|
|Medical School Transcript|
|Medical Student Performance Evaluation (MSPE)|
|Additional Documents for Foreign Medical School Applicants|
|Foreign Medical License|
|ECFMG Status Report|
|July 1, 2020||ERAS opens for application submission|
|August 12, 2020||Program may begin reviewing applications|
|August 31, 2020||Application deadline for the 2021 academic year|
|September 11, 2020||Virtual Interview Date|
|September 18, 2020||Virtual Interview Date|
|September 25, 2020||Virtual Interview Date|
|October 2, 2020||Virtual Interview Date|
|October 16, 2020||Virtual Interview Date|
|October 23, 2020||Virtual Interview Date|
|December 2, 2020||MATCH DAY|
The Developmental Therapeutics Program fosters cancer-focused inter-disciplinary research among basic scientists and clinical researchers who are focused on the discovery, development and delivery of new anti-cancer therapies. Our program faculty promote interaction and collaboration among Developmental Therapeutics members, which stimulates breakthroughs in diagnosis, treatment and prevention of cancer. This two year fellowship educates fellows to reduce the cancer burden through integration of the processes of discovery, development, and delivery of new anticancer agents.
Our two year Thoracic Oncology Felllowship aims to train oncology fellows in state‐of‐the‐art high quality care for patients with Thoracic Malignancies and in the conduct of clinical and translational research related to such patients. This program will expose fellows to patients with thoracic malignancies within a world‐class multidisciplinary clinical program. By regularly seeing and assessing these patients, they will learn state‐of‐the‐art clinical management and through involvement in the conduct of clinical and translational research, the methodology for developing new treatments in the future.